BDBM516618 (31R,33S,35R,Z)-32-(2-(3-acetyl-1H- pyrazolo[3,4-c]pyridin-1-yl)acetyl)-66- bromo-11H-8-oxa-32,5-diaza-6(2,3)- pyridina-1(1,4)-triazola-3(5,3)- bicyclo[3.1.0]hexanacyclononaphan-4-one::US11053253, Cmp No. T-27::US11718626, Compound T-27::US11814391, Compound 48

SMILES CC(=O)c1nn(CC(=O)N2[C@@H]3C[C@]33C[C@H]2C(=O)Nc2nc(Br)ccc2COCc2cn(C3)nn2)c2cnccc12

InChI Key InChIKey=NPMGJRZVFUBPIO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 516618   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM516618(US11053253, Cmp No. T-27 | (31R,33S,35R,Z)-32-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
Go to US Patent

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM516618(US11053253, Cmp No. T-27 | (31R,33S,35R,Z)-32-(2-(...)
Affinity DataIC50: 1.00E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/8/2024
Entry Details
Go to US Patent